knowledge -WSS

knowledge

author：fashion 2025-08-19 18:03:38 - browse：561

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Why you get paid to donate plasma but not blood

WSS

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Robert Kennedy Jr.'s presidential campaign attracts GOP

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Eli Lilly’s Mounjaro succeeds in second weight

FDA approves first new drug developed for postpartum depression

knowledge

knowledge

knowledge

Walensky prepares to leave CDC — and Congress — behind

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Sports medicine is finally prioritizing gender equality

The thinking behind the controversial eating disorder chatbot Tessa

BioMarin wins approval for gene therapy to treat hemophilia A

Senate panel passes drug pricing bills, but drops one PBM reform

Activists slam private health insurers over coverage restrictions

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Duchenne breakthrough therapy leaves behind pioneering families

Reanimated hearts work just as well for transplants, study finds

knowledge

FDA approves first new drug developed for postpartum depression

Bispecific antibodies are next new thing in cancer immunotherapy

Reanimated hearts work just as well for transplants, study finds

Manchin plays down potential 3rd

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

What we know about the American soldier detained in North Korea

hotspot

focus

Wikipedia

hotspot